Description

2-[[3-(n-Methylacetylamino)-2,4,6-Triiodophenyl]Oxy]Hexanoic Acid is a specialized iodinated organic compound, serving as a key intermediate in the synthesis of advanced X-ray contrast media. Its molecular structure, featuring a triiodinated aromatic ring, is critical for imparting the high radiopacity required in diagnostic imaging agents. This high-purity intermediate is essential for pharmaceutical manufacturers and advanced research facilities developing next-generation non-ionic contrast agents for computed tomography (CT) and angiography.

Application

• Pharmaceutical Intermediate: Primary building block for the synthesis of non-ionic, low-osmolar X-ray contrast media.
• Diagnostic Imaging Agent Precursor: Used in the research and production of iodinated compounds for enhanced vascular and organ imaging in CT scans.
• Medical Research & Development: Critical reagent in the development of novel contrast agents with improved safety profiles and pharmacokinetics.
• Radiopharmaceutical Synthesis: Serves as a starting material for specialized compounds used in diagnostic radiochemistry.
• Chemical Reference Standard: Used as a high-purity standard for analytical method development and quality control in pharmaceutical labs.

Basic Information

Product Name	2-[[3-(n-Methylacetylamino)-2,4,6-Triiodophenyl]Oxy]Hexanoic Acid
CAS No.	24340-19-0
Molecular Formula	C15H19I3N2O4
Molecular Weight	704.04 g/mol
Synonyms	2-[[3-(N-Methylacetamido)-2,4,6-triiodophenoxy]hexanoic Acid; 5-[N-Methyl-N-(2,3,5-triiodobenzoyl)glycyl]amino-2,4,6-triiodoisophthalic Acid Derivative; Iohexol Intermediate; Ioversol Related Compound; Iopamidol Synthetic Precursor; 3-Acetamido-2,4,6-triiodo-5-(2-ethoxyethoxyethoxy)benzoic Acid Analog; Triiodinated Phenyl Ether Derivative
EINECS	Contact for details

Quality Control

Our 2-[[3-(n-Methylacetylamino)-2,4,6-Triiodophenyl]Oxy]Hexanoic Acid is manufactured under strict quality systems suitable for pharmaceutical intermediate applications. Each batch is subjected to rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets exacting specifications. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment. We support compliance with cGMP, ICH Q7, and relevant pharmacopeial guidelines for active pharmaceutical ingredients (APIs) and key starting materials.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its light-sensitive and easily oxidized nature, it is recommended to store the product under an inert atmosphere (e.g., nitrogen or argon) for long-term stability. Keep away from heat, open flames, and incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0% Any single impurity ≤0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	≤20 ppm
Loss on Drying	≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.